Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNITED THERAPEUTICS (UTHR) Other Working Capital Changes: 2009-2024

Historic Other Working Capital Changes for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $55.6 million.

  • UNITED THERAPEUTICS's Other Working Capital Changes fell 58.49% to -$67.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.8 million, marking a year-over-year decrease of 66.89%. This contributed to the annual value of $55.6 million for FY2024, which is 32.85% down from last year.
  • Latest data reveals that UNITED THERAPEUTICS reported Other Working Capital Changes of $55.6 million as of FY2024, which was down 32.85% from $82.8 million recorded in FY2023.
  • In the past 5 years, UNITED THERAPEUTICS's Other Working Capital Changes registered a high of $150.6 million during FY2022, and its lowest value of -$20.2 million during FY2020.
  • Moreover, its 3-year median value for Other Working Capital Changes was $82.8 million (2023), whereas its average is $96.3 million.
  • As far as peak fluctuations go, UNITED THERAPEUTICS's Other Working Capital Changes plummeted by 110.14% in 2020, and later soared by 658.91% in 2021.
  • Over the past 5 years, UNITED THERAPEUTICS's Other Working Capital Changes (Yearly) stood at -$20.2 million in 2020, then surged by 658.91% to $112.9 million in 2021, then skyrocketed by 33.39% to $150.6 million in 2022, then crashed by 45.02% to $82.8 million in 2023, then plummeted by 32.85% to $55.6 million in 2024.